| Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention Y Liu Journal of the American Society of Nephrology 15 (1), 1-12, 2004 | 1653 | 2004 |
| Renal fibrosis: new insights into the pathogenesis and therapeutics Y Liu Kidney international 69 (2), 213-217, 2006 | 1555 | 2006 |
| Cellular and molecular mechanisms of renal fibrosis Y Liu Nature Reviews Nephrology 7 (12), 684-696, 2011 | 1534 | 2011 |
| Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis J Yang, Y Liu The American journal of pathology 159 (4), 1465-1475, 2001 | 1192 | 2001 |
| New insights into epithelial-mesenchymal transition in kidney fibrosis Y Liu Journal of the American Society of Nephrology 21 (2), 212-222, 2010 | 1136 | 2010 |
| Wnt/β-catenin signaling promotes renal interstitial fibrosis W He, C Dai, Y Li, G Zeng, SP Monga, Y Liu Journal of the American Society of Nephrology 20 (4), 765-776, 2009 | 688 | 2009 |
| Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis Y Li, J Yang, C Dai, C Wu, Y Liu The Journal of clinical investigation 112 (4), 503-516, 2003 | 585 | 2003 |
| Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis J Yang, Y Liu Journal of the American Society of Nephrology 13 (1), 96-107, 2002 | 524 | 2002 |
| Wnt/β-catenin signaling promotes podocyte dysfunction and albuminuria C Dai, DB Stolz, LP Kiss, SP Monga, LB Holzman, Y Liu Journal of the American Society of Nephrology 20 (9), 1997-2008, 2009 | 490 | 2009 |
| Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria Y Li, YS Kang, C Dai, LP Kiss, X Wen, Y Liu The American journal of pathology 172 (2), 299-308, 2008 | 455 | 2008 |
| Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling L Zhou, Y Li, D Zhou, RJ Tan, Y Liu Journal of the American Society of Nephrology 24 (5), 771-785, 2013 | 398 | 2013 |
| Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy X Tan, Y Li, Y Liu Journal of the American Society of Nephrology 17 (12), 3382-3393, 2006 | 390 | 2006 |
| Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action Y Liu American Journal of Physiology-Renal Physiology 287 (1), F7-F16, 2004 | 375 | 2004 |
| Paricalcitol inhibits renal inflammation by promoting vitamin D receptor–mediated sequestration of NF-κB signaling X Tan, X Wen, Y Liu Journal of the American Society of Nephrology 19 (9), 1741-1752, 2008 | 355 | 2008 |
| Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy J Yang, RW Shultz, WM Mars, RE Wegner, Y Li, C Dai, K Nejak, Y Liu The Journal of clinical investigation 110 (10), 1525-1538, 2002 | 353 | 2002 |
| Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury W He, YS Kang, C Dai, Y Liu Journal of the American Society of Nephrology 22 (1), 90-103, 2011 | 336 | 2011 |
| Wnt/β-catenin signaling and kidney fibrosis RJ Tan, D Zhou, L Zhou, Y Liu Kidney international supplements 4 (1), 84-90, 2014 | 291 | 2014 |
| Matrix metalloproteinases in kidney homeostasis and diseases RJ Tan, Y Liu American journal of physiology-renal physiology 302 (11), F1351-F1361, 2012 | 290 | 2012 |
| Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation JL Xia, C Dai, GK Michalopoulos, Y Liu The American journal of pathology 168 (5), 1500-1512, 2006 | 290 | 2006 |
| Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis S Hao, W He, Y Li, H Ding, Y Hou, J Nie, FF Hou, M Kahn, Y Liu Journal of the American Society of Nephrology 22 (9), 1642-1653, 2011 | 275 | 2011 |
DONG ZHOUUniversity of Connecticut School of Medicineuchc.edu의 이메일 확인됨